Suche starten De menü ClientConnect
Suche starten
Top-5-Suchergebnisse Alle Ergebnisse anzeigen Erweiterte Suche
Häufigste Suchbegriffe
Meistbesuchte Seiten
    Referenz: 20200618
    Veröffentlichungsdatum: 13 August 2020

    Projektträger – zwischengeschaltetes Finanzinstitut




    Programme Loan to group risk sharing operations under the pan-European Guarantee Fund (EGF) in the EGF-participating EU Member States. Sub-operations will be intermediated risk sharing operations with acceptable financial institutions such as banks, leasing companies, etc. As an instrument under an Impact Finance Mandate, sub-operations would need to comply with the General Mandate Risk Principles.


    Part of the Pan-European Guarantee Fund in response to COVID-19, this Programme Loan aims to mobilise funding resources to respond to the economic impact of the COVID-19 pandemic outbreak by ensuring that eligibile entities and primarily small and medium-sized enterprises (SMEs) in the participating Member States have sufficent liquidity available and access to finance to weather the rapidly unfolding crisis and are able to continue their development in the medium to long-term. The supported final recipients are the ones considered: (i) viable in the long-term; (ii) meet the lender's or other Financial Intermediaries' requirements for commercial financing, were it not for the economic impact of the COVID-19 pandemic. In line with the pan-European Guarantee Fund, this is a limited-time intervention.


    Vorgeschlagene EIB-Finanzierung (voraussichtlicher Betrag)

    EUR 4500 million

    Gesamtkosten (voraussichtlicher Betrag)

    EUR 13067 million


    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.


    Final beneficiaries will be requested to comply with applicable national and EU legislation, as appropriate.


    Genehmigt - 13/10/2020


    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).


    EU-Länder Gesundheit Durchleitungsdarlehen